This site is intended for health professionals only

Editor’s pick

Advances in treatment for head and neck cancer
Advances in treatment for head and neck cancer
Delivering safer IV medication
Delivering safer IV medication
The Dunfermline experience of iron dextran
The Dunfermline experience of iron dextran
Ward delivery of intravenous fluids
Ward delivery of intravenous fluids
Health economics of treating multidrug-resistant Gram-positive infections: a qualitative critique
Health economics of treating multidrug-resistant Gram-positive infections: a qualitative critique
Certolizumab pegol for the treatment of Crohn’s disease
Certolizumab pegol for the treatment of Crohn’s disease
Drug-eluting beads for chemoembolisation in oncology
Drug-eluting beads for chemoembolisation in oncology
TNF-alpha-targeted therapy in inflammatory arthritides: a valuable option?
TNF-alpha-targeted therapy in inflammatory arthritides: a valuable option?
FDA approves fosphenytoin sodium injection
FDA approves fosphenytoin sodium injection
Doctors “lack information” on MRSA
Doctors “lack information” on MRSA
Vaccine shows promise in mouse model of breast cancer
Vaccine shows promise in mouse model of breast cancer
UK pharmaceutical workforce shrinking
UK pharmaceutical workforce shrinking
1 … 208 209 210 211 212 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x